In the present study, IL-2 was assumed to influence, even at low serum levels, the self-limited evolution of clinical manifestations, culminating in the spontaneous resolution of infection in asymptomatic individuals [2, 23]—a role shared by IL-17, as previously discussed. The gene discussed is IL17A; the disease is infection.